May 27, 2020
Amid the COVID-19 Pandemic, Neurologists in Canada Report Pulling Back from EMD Serono’s Mavenclad and Sanofi Genzyme’s Lemtrada, While Roche’s Ocrevus Stalls, According to Spherix Global Insights
- /
- /
COVID-19 is unprecedented and rapidly changing situation. Get the latest public health information from CDC: https://www.coronavirus.gov Stay Healthy, Stay Home…